Literature DB >> 8822349

Effects of sodium fluoride and alendronate on the bone mineral in minipigs: a small-angle X-ray scattering and backscattered electron imaging study.

P Fratzl1, S Schreiber, P Roschger, M H Lafage, G Rodan, K Klaushofer.   

Abstract

Sodium fluoride (NaF), which stimulates bone formation, and bisphosphonates, which reduce bone resorption, are both used in the treatment of osteoporosis, and are binding to bone mineral. In this study, using small-angle X-ray scattering and backscattered electron imaging, we analyzed the bone mineral in the vertebrae of minipigs treated with fluoride, with the bisphosphonate alendronate (ALN), or with vehicle. All specimens were investigated blindly. A slight increase in the average thickness of the mineral crystals as well as changes in the structure of the mineral/collagen composite were found in the case of fluoride-treated animals. No differences were found between ALN-treated animals and controls. The changes produced by fluoride are in the same direction as seen in bones from patients treated with NaF, albeit much smaller. They also correlate quantitatively with the reduction in biomechanical properties of bone in fluoride-treated minipigs found in an earlier study with the same animals. These findings suggest that small changes in the structure of the mineral/collagen composite in bone may considerably affect its biomechanical properties. It also emphasizes the delicate balance between the increase of bone mass and deterioration of bone material properties for the effect of fluoride on the biomechanical properties of bone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822349     DOI: 10.1002/jbmr.5650110214

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

Review 1.  Infrared assessment of bone quality: a review.

Authors:  Eleftherios P Paschalis; Richard Mendelsohn; Adele L Boskey
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

2.  Increasing fluoride content deteriorates rat bone mechanical properties.

Authors:  Taraneh Rezaee; Mary L Bouxsein; Lamya Karim
Journal:  Bone       Date:  2020-04-19       Impact factor: 4.398

3.  Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs.

Authors:  Shojiro Akahoshi; Akinori Sakai; Shinobu Arita; Satoshi Ikeda; Yoshiomi Morishita; Hideki Tsutsumi; Masako Ito; Ayako Shiraishi; Toshitaka Nakamura
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

4.  Osteopontin deficiency increases bone fragility but preserves bone mass.

Authors:  Philipp J Thurner; Carol G Chen; Sophi Ionova-Martin; Luling Sun; Adam Harman; Alexandra Porter; Joel W Ager; Robert O Ritchie; Tamara Alliston
Journal:  Bone       Date:  2010-02-18       Impact factor: 4.398

Review 5.  Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects.

Authors:  Barbara M Misof; Nadja Fratzl-Zelman; Eleftherios P Paschalis; Paul Roschger; Klaus Klaushofer
Journal:  Bonekey Rep       Date:  2015-02-11

6.  Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH-ASBMR SABRE Project.

Authors:  Richard Eastell; Eric Vittinghoff; Li-Yung Lui; Charles E McCulloch; Imre Pavo; Arkadi Chines; Sundeep Khosla; Jane A Cauley; Bruce Mitlak; Douglas C Bauer; Mary Bouxsein; Dennis M Black
Journal:  J Bone Miner Res       Date:  2021-09-24       Impact factor: 6.390

7.  Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats.

Authors:  S Lalla; L A Hothorn; N Haag; R Bader; F Bauss
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

Review 8.  Fragility of Bone Material Controlled by Internal Interfaces.

Authors:  Wolfgang Wagermaier; Klaus Klaushofer; Peter Fratzl
Journal:  Calcif Tissue Int       Date:  2015-03-14       Impact factor: 4.333

9.  Anabolic and antiresorptive actions of locally delivered bisphosphonates for bone repair: A review.

Authors:  I Qayoom; D B Raina; A Širka; Š Tarasevičius; M Tägil; A Kumar; L Lidgren
Journal:  Bone Joint Res       Date:  2018-11-03       Impact factor: 5.853

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.